Belzutifan
In the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.
We can provide high-quality Belzutifan and its derived impurities.
-
CAS1672668-24-4
-
CatalogHY-125840
-
Molecular Weight383.34
-
Molecular FormularC17H12F3NO4S
